Inhibition of integrin β3, a binding partner of kallistatin, leads to reduced viability, invasion and proliferation in NCI-H446 cells

BACKGROUND: Kallistatin is a serine proteinase inhibitor and heparin-binding protein. It is considered an endogenous angiogenic inhibitor. In addition, multiple studies demonstrated that kallistatin directly inhibits cancer cell growth. However, the molecular mechanisms underlying these effects rema...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Cell Int
Main Authors: Wang, Guoquan, Wang, Xiao, Huang, Xiaoping, Yang, Huiyong, Pang, Suqiu, Xie, Xiaolan, Zeng, Shulan, Lin, Junsheng, Diao, Yong
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Primary Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5134261/
https://ncbi.nlm.nih.gov/pubmed/27980455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-016-0365-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados